Wnt Signaling in Bone Development and Healing

Wnt signalling encompasses a family of secreted glycoproteins that orchestrate skeletal formation, remodelling and repair through two principal routes: the canonical (β-catenin-dependent) pathway and diverse non-canonical (β-catenin-independent) cascades. During embryonic skeletogenesis, activation of the canonical pathway promotes differentiation of mesenchymal stem cells into osteoblasts, while simultaneously restraining adipogenic and chondrogenic fates. In the mature skeleton, Wnt-driven stabilisation of β-catenin in osteoblast precursors fosters bone formation, whereas modulation of non-canonical routes regulates cell polarity, migration and mechanotransduction in response to loading. Osteocytes secrete sclerostin, a potent inhibitor of canonical signalling, thus fine-tuning bone mass by tempering osteoblast activity and enhancing osteoclastogenesis when required. Following fracture, temporal regulation of Wnt signals governs the transition from cartilage callus formation to mineralised bone, with early suppression of β-catenin permitting chondrogenesis and later activation driving osteogenesis. Therapeutic strategies targeting extracellular modulators—such as sclerostin-neutralising antibodies or DKK-family antagonists—have demonstrated efficacy in augmenting bone density and accelerating repair. Emerging insights into post-translational modifications and receptor co-factors promise further refinement of interventions designed to harness Wnt pathways for clinical benefit.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Wnt Signaling in Bone Development and Healing publication trend

The graph below shows the total number of articles in wnt signaling in bone development and healing across all publications each year (not limited to Nature Index journals).

Technical terms

Wnt proteins: Secreted glycoproteins that initiate signalling cascades critical to cell fate decisions.

Canonical Wnt signalling: Pathway in which Wnt binding stabilises β-catenin, allowing its nuclear translocation and transcriptional activation.

Non-canonical Wnt signalling: β-catenin-independent pathways that regulate cytoskeletal dynamics, cell movement and calcium fluxes.

β-catenin: Intracellular mediator whose accumulation and nuclear entry drive expression of osteogenic genes.

Mesenchymal stem cell: Multipotent progenitor capable of differentiating into osteoblasts, chondrocytes or adipocytes.

Osteoblast: Bone-forming cell responsible for matrix synthesis and mineralisation.

Osteoclast: Multinucleated cell that resorbs mineralised bone tissue.

Sclerostin: Osteocyte-derived inhibitor of canonical Wnt signalling that regulates bone mass.

O-GlcNAcylation: Post-translational modification involving attachment of N-acetylglucosamine, modulating protein function.

References

1. Wnt/β-catenin signaling components and mechanisms in bone formation, homeostasis, and disease. Bone Research (2024).
2. O-GlcNAcylation in the osteoblast lineage—boosting the complexity of Wnt-stimulated bone formation. EMBO Reports (2024).
3. Beta-Catenin Signaling Plays a Disparate Role in Different Phases of Fracture Repair: Implications for Therapy to Improve Bone Healing. PLOS Medicine (2007).
4. Wnt Signaling Stimulates Osteoblastogenesis of Mesenchymal Precursors by Suppressing CCAAT/Enhancer-binding Protein α and Peroxisome Proliferator-activated Receptor γ*. Journal of Biological Chemistry (2007).